Ann: Investor Update Webinar Invitation, page-300

My view - we have cash, we have a team that realises it has made mistakes (not overly owned them however) but we still have a platform of tests that will be useful in the future. We may have missed the Covid rush, however we have a series of tests not too far away that will be useful, and I think still in demand.

Timing not great, delivery today certainly not great, downside risk to me is now minded, cash in the bank to do what we need, ad a realisation that we need to improve.

I'm holding, would have sold at 18 if I was quick enough but now this is in the bottom drawer (like it was last time) for me. Seen $1 million come and go which is pretty frustrating and early retirement has now gone from the near term - live and learn ........ again.